FOLIO 04 · Build-up
How the $230,000 number is built
The headline annual figure is not a single line. It stacks three losses that practices typically count separately, even when they cumulatively land on the same income statement. We show the build-up here so that a practice manager can compare each line to their own books.
Start with throughput. A two-provider primary care practice typically schedules 20 patient slots a day across the two clinicians, working 220 days a year (252 weekdays minus federal holidays, PTO, CME, and a buffer for admin half-days). That gives 4,400 scheduled appointments a year. At the MGMA 2024 median no-show rate of 19 percent, 836 of those slots are missed. At an average primary care reimbursement of $200 per encounter (a blended commercial and Medicare rate; Medicaid runs lower, $90 to $130, and commercial preventive visits run higher, $240 to $290), the direct lost billable revenue is $167,200 for the year.
That is the first line. The second line is unrecovered fixed cost. The rooms are rented whether the patient shows or not. The medical assistant is on payroll. The EHR seat costs the same. Fixed cost per slot at a typical primary care practice runs $40 to $60 (a rule-of-thumb derived from MGMA 2024 cost-and-revenue tables: total operating cost minus variable supplies divided by total slots). For 836 missed slots, that is $33,440 to $50,160 of fixed cost unrecovered, none of which can be reassigned to billable work on the same day for most practices that lack an active cancellation waitlist.
The third line is downstream care loss. Primary care no-shows are not just one missed visit. They are missed lab orders, missed prescription renewals that cascade into ED visits, missed referrals that delay specialist care, and missed care-gap closure that lowers HEDIS scores and downstream value-based reimbursement. BMJ 2019 (Williamson et al, retrospective cohort of 800,000 UK patients) found that patients who missed two or more appointments had a 1.5x higher all-cause mortality at five years. That is a population-level signal, not a clean dollar figure for a single practice, but it shows up financially in lower Star Ratings, lower MIPS scores, lower commercial quality bonuses, and worse panel risk-adjusted PMPM in value-based contracts. A conservative attribution of $30,000 to $60,000 a year in downstream impact for a typical two-provider practice is supported by recent ACO performance modelling published by NAACOS.
Adding the three lines: direct revenue $167,200, plus unrecovered fixed cost $33,440 to $50,160, plus downstream care impact $30,000 to $60,000. That puts the total economic loss at $230,000 to $277,000 for a typical two-provider primary care practice operating at MGMA median rates. The rounding to $230K is conservative. The full number is closer to $250K for most groups.
| Component | Annual amount | Source / method |
|---|
| Direct billed revenue lost | $167,200 | 836 missed slots x $200 avg primary care reimbursement |
| Unrecovered fixed cost | $33,440 to $50,160 | 836 slots x $40 to $60 fixed cost per slot (MGMA 2024) |
| Downstream care impact (est.) | $30,000 to $60,000 | HEDIS, MIPS, ACO PMPM impact, NAACOS modelling |
| Total economic loss | $230,000 to $277,000 | Sum of the three lines, rounded conservatively |
FOLIO 05 · Benchmark
The 19 percent MGMA benchmark, in context
The 19 percent figure is the MGMA 2024 DataDive median for family medicine and internal medicine primary care practices. Top quartile sits at or below 12 percent. Bottom quartile sits above 27 percent. A practice at the bottom quartile is losing roughly 1.4x the dollars of a practice at the median, holding visit volume and reimbursement constant. The gap between quartiles is wider than it has been in any year since MGMA began reporting the metric.
This widening is the headline finding for 2026. The median has improved slightly (from 21 percent in 2018 to 19 percent in 2024) because the rise of text-first reminders has helped most practices a little. But the bottom quartile has worsened, driven mostly by Medicaid-skewed and safety-net practices facing post-PHE coverage churn. The takeaway: aggregate looks healthier, but the practices most affected are getting hit harder. For a typical private-pay primary care practice, the median is the right reference. For an FQHC or safety-net clinic, the bottom-quartile or HRSA UDS data set is the right reference (see the FQHC no-show folio).
FOLIO 06 · FQHC vs private
FQHC and safety-net practices: a different number
Primary care averages compress practice types that should not be compared 1-to-1. A typical private-pay or commercial-mix family medicine practice in a suburb runs at the 19 percent MGMA median. A federally qualified health center serving a Medicaid and uninsured population runs at 28 to 35 percent per HRSA UDS data, with some inner-city FQHCs reporting above 40 percent for behavioral health appointments and 32 to 34 percent for medical visits.
The drivers are not patient indifference. They are structural. Transportation gaps are the single biggest cited reason for FQHC no-shows (32 percent of cited reasons in HRSA UDS qualitative data), followed by competing childcare or work obligations (24 percent), and forgotten appointments (20 percent). Compare to private-pay where forgotten appointments dominate at 60 percent per JGIM 2016. The intervention mix that works for a private-pay practice (SMS reminders, two-stage confirmation, written policy) is necessary but insufficient for an FQHC. Effective FQHC programs add rideshare integration, on-site or telehealth-flexible scheduling, and warm-handoff care navigation.
If you are a primary care practice with a payer-mix more than 30 percent Medicaid, the right benchmark to plan against is 25 to 30 percent, not 19 percent. Setting your improvement targets to the wrong benchmark wastes intervention spend and demoralizes staff. The Medicaid no-show folio has the payer-by-payer math.
FOLIO 07 · Recovery
What primary care practices that beat the benchmark actually do
The top-quartile MGMA practices share four operational habits. They are not exotic. They are simply done consistently, with measurement, and with staff buy-in. We list them in order of effect on the no-show rate, with the evidence base and a rough cost.
- Two-stage SMS reminders at 48 hours and 2 hours. The JMIR 2019 meta-analysis of 14 RCTs found 28 to 38 percent reduction in no-shows from SMS reminders, with the two-stage approach at the upper end. Cost is about $0.01 to $0.04 per SMS depending on volume tier and vendor. For 4,400 scheduled appointments a year and two messages each, that is 8,800 SMS per year, $88 to $352. See the SMS reminder ROI folio for the worked math.
- Two-way confirmation that requires a reply. Adds 15 percent additional reduction on top of one-way reminders, per JMIR follow-up data. The patient must reply YES or NO. If NO or no reply, the slot enters the waitlist queue. Most modern patient engagement platforms (Weave, NexHealth, SolutionReach, Klara, Phreesia) support this natively. See the two-way confirmation folio.
- Active cancellation waitlist. Fills 30 to 45 percent of cancelled or no-show slots same-day per MGMA 2024 practice data. The mechanism is simple: when a patient cancels or no-shows, an SMS goes to the top 5 patients on a same-day-availability list, first-to-confirm gets the slot. Requires PMS support (Athena, eClinicalWorks, Greenway, Epic Community Connect all have it). See the cancellation waitlist folio.
- Written no-show policy with consistent enforcement. 15 to 25 percent reduction per AMA practice management guidance. The policy itself matters less than the consistency of enforcement. A policy that documents a $25 to $50 charge after the second no-show, applied uniformly, sets expectations. State Medicaid rules restrict no-show fees for Medicaid patients in 38 states (see the no-show fee by state folio). Have your front desk hand a printed copy at the first visit. See the policy template folio for sample language.
Stacked, these four interventions take a 19 percent practice to roughly 11 to 13 percent within 90 days, which is at or just above the top-quartile MGMA benchmark. The cost is approximately $400 to $1,200 a month in vendor fees plus the SMS volume tier, against a typical recovery of $5,000 to $11,000 a month in lifted visit volume. ROI is positive within month one for most practices that move from no reminders or single-stage email reminders.
FOLIO 08 · Worked example
Worked example: a 5-provider primary care group going from 22 to 12 percent
Take a 5-provider family medicine group running 100 slots a day, 220 days a year, $215 average reimbursement (commercial-heavy mix). That is 22,000 scheduled appointments a year. At a starting 22 percent no-show rate, that is 4,840 missed appointments, costing $1,040,600 in direct revenue plus an estimated $194,000 in fixed cost and $130,000 in downstream care loss. Total annual loss roughly $1.36M.
Implementing the four interventions above, and assuming a realistic 10-point rate reduction over six months (down to 12 percent, at the top quartile), the practice now misses 2,640 appointments a year. Direct revenue loss falls to $567,600. Fixed cost loss falls to about $106,000. Downstream loss roughly halves to $70,000. New total annual loss: $743,600. Annual recovery: $616,400.
Intervention cost: about $1,800 a month vendor fees (a mid-tier patient engagement platform sized for 5 providers) plus $300 to $400 a month in SMS volume. Annual cost roughly $26,400. Net first-year return: $590,000. ROI: 22x in the first 12 months. After year one the recovery is mostly run-rate, lifted directly into the practice's net operating income.
Calculation method is a deterministic build-up using MGMA 2024 medians and JMIR 2019 reduction effects. Not a single-practice case study. We do not invent quoted practice managers.
FOLIO 09 · What does not work
Three interventions that look right but do not move the number
Not every intervention earns its place. Three deserve specific scrutiny because vendor marketing routinely overstates their effect on primary care practices specifically.
- Email-only reminders. The JMIR 2019 meta-analysis put email-only reduction at 15 to 20 percent versus 28 to 38 percent for SMS. The gap is open rates: SMS open in seconds, email opens in days. Many small practices still default to email because the PMS makes it free. The opportunity cost of staying on email is roughly 5 to 10 percentage points of no-show rate, which is $50K to $100K a year for a 2-provider practice.
- Voice-call IVR reminders. Effective in 2010, less effective in 2026. Patients ignore unknown calls. Vendor data shows under 40 percent of voice reminders are listened to past the second sentence. Voice still has a role for elderly patient populations and for second-touch escalation after a no-reply on SMS, but should not be primary.
- Overbooking by the full no-show rate. Common mistake. If your rate is 19 percent, overbooking by 19 percent creates chaos on days when nearly everyone shows. Operations research consensus is to overbook by 60 to 70 percent of your no-show rate. For a 19 percent practice, that is 11 to 13 percent overbook. See the overbooking folio.
FOLIO 10 · Related
Related folios
FOLIO 11 · Margin notes
Frequently asked questions
What is the average primary care no-show rate in 2026?+
MGMA 2024 DataDive reports a median primary care no-show rate of 19 percent, with top-quartile practices at 12 percent or lower. This sits inside the 23 percent overall healthcare average reported by the JAMA 2022 meta-analysis of 5.9 million appointments. Primary care runs a few points under that average because of strong establish-patient relationships and panel continuity. FQHCs and safety-net clinics run materially higher, in the 28 to 35 percent band per HRSA UDS reporting.
How much does a no-show cost a primary care practice annually?+
A two-provider primary care practice running 20 slots per day, 220 working days, at $200 average reimbursement per visit and a 19 percent no-show rate loses about $167,200 in direct billed revenue and $230,000 to $280,000 in total economic loss once unrecovered fixed cost (rent, MA salary, EHR seats) is added. Larger 5-provider groups scale linearly to the $500K to $700K range. The MGMA 2024 benchmarks support the same calculation across cohort sizes.
Why is the primary care no-show rate higher than for surgical specialties?+
Three structural reasons. First, primary care appointments are lower-stakes per visit, so the perceived cost of skipping is lower for the patient. Second, primary care panels include more transient patients (new movers, between-job patients losing coverage, Medicaid churn) than long-standing specialty referrals. Third, primary care often books further out (3 to 8 weeks) than specialty follow-ups (1 to 2 weeks), and forgetting risk compounds with lead time per the JGIM 2016 reasons analysis.
What is the MGMA top-quartile no-show rate for primary care?+
MGMA 2024 reports the top-quartile primary care no-show rate at 12 percent or lower. The median is 19 percent. The bottom quartile sits above 27 percent. Practices in the top quartile typically combine two-stage SMS reminders, a written cancellation policy enforced consistently, an active cancellation waitlist, and same-day open-access scheduling slots that reduce 3+ week booking horizons.
Is the no-show rate getting better or worse in 2026?+
Mixed. Vendor-reported reduction tools and the shift to text-first reminders have brought the median down roughly 2 percentage points since 2018 (MGMA 2024 vs 2018 historical comparison). However the gap between top and bottom quartile widened, and Medicaid-skewed practices saw the rate creep up after the public health emergency unwound and continuous-enrolment ended in April 2023. So aggregate is slightly better, but the variance is wider.